Zymeworks (ZYME) Current Deferred Revenue (2021 - 2026)

Zymeworks has disclosed Current Deferred Revenue across 6 years of filings, most recently posting $2.1 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $2.1 million, down 94.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 94.55% YoY), and the FY2025 annual result was $2.4 million, down 90.55% from the prior year.
• Current Deferred Revenue came in at $2.1 million for Q1 2026 at Zymeworks, down from $2.4 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $41.8 million in Q3 2024 to a low of $93000.0 in Q3 2023.
• The 5-year median for Current Deferred Revenue is $3.8 million (2025), against an average of $16.7 million.
• Across the five-year window, Current Deferred Revenue slumped 99.72% in 2023 and surged 44840.86% in 2024, its largest moves.
• Zymeworks' Current Deferred Revenue stood at $2.4 million in 2022, then surged by 57.2% to $3.7 million in 2023, then soared by 592.08% to $25.6 million in 2024, then plunged by 90.55% to $2.4 million in 2025, then retreated by 14.06% to $2.1 million in 2026.
• The last three Current Deferred Revenue figures came in at $2.1 million (Q1 2026), $2.4 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.